Financhill
Buy
54

SRE Quote, Financials, Valuation and Earnings

Last price:
$93.56
Seasonality move :
1.55%
Day range:
$92.49 - $93.61
52-week range:
$61.90 - $95.74
Dividend yield:
2.76%
P/E ratio:
28.81x
P/S ratio:
4.44x
P/B ratio:
1.96x
Volume:
3.3M
Avg. volume:
4.4M
1-year change:
8.77%
Market cap:
$61.1B
Revenue:
$13B
EPS (TTM):
$3.25
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $11.4B $13.1B $15.6B $15.8B $13B
Revenue Growth (YoY) 5.02% 15.05% 19.09% 1.59% -18%
 
Cost of Revenues $8.1B $9.4B $11.4B $12.1B $9.4B
Gross Profit $3.3B $3.6B $4.2B $3.7B $3.5B
Gross Profit Margin 28.87% 27.9% 26.75% 23.71% 27.2%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $543M $596M $635M $677M $693M
Other Inc / (Exp) -$372M -$1.5B -$261M $52M $61M
Operating Expenses $543M $596M $635M $677M $693M
Operating Income $2.7B $3B $3.5B $3.1B $2.8B
 
Net Interest Expenses $1.1B $1.2B $1.1B $1.3B $1.3B
EBT. Incl. Unusual Items $1.5B $219M $1.3B $2.6B $2.1B
Earnings of Discontinued Ops. $1.9B -- -- -- --
Income Tax Expense $249M $99M $556M $490M $219M
Net Income to Company $4.1B $1.5B $2.3B $3.6B $3.5B
 
Minority Interest in Earnings $172M $145M $146M $543M $638M
Net Income to Common Excl Extra Items $2.3B $1.5B $2.3B $3.6B $3.5B
 
Basic EPS (Cont. Ops) $6.47 $2.01 $3.32 $4.81 $4.44
Diluted EPS (Cont. Ops) $6.44 $2.00 $3.31 $4.79 $4.42
Weighted Average Basic Share $582.2M $623.5M $630.3M $630.3M $633.8M
Weighted Average Diluted Share $584.5M $626.1M $632.8M $632.7M $637.9M
 
EBITDA $4.4B $4.9B $5.5B $5.3B $5.3B
EBIT $2.7B $3B $3.5B $3.1B $2.8B
 
Revenue (Reported) $11.4B $13.1B $15.6B $15.8B $13B
Operating Income (Reported) $2.7B $3B $3.5B $3.1B $2.8B
Operating Income (Adjusted) $2.7B $3B $3.5B $3.1B $2.8B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $3.2B $3.8B $3.3B $2.7B $3.2B
Revenue Growth (YoY) 18.04% 21.38% -13.87% -19.12% 18.9%
 
Cost of Revenues $2.4B $2.9B $2.5B $2.1B $2.4B
Gross Profit $791M $985M $861M $549M $821M
Gross Profit Margin 24.98% 25.62% 26% 20.5% 25.79%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $151M $162M $169M $175M $194M
Other Inc / (Exp) -$1.6B -$169M -$16M $39M --
Operating Expenses $151M $162M $169M $175M $194M
Operating Income $640M $823M $692M $374M $627M
 
Net Interest Expenses $261M $289M $311M $325M $405M
EBT. Incl. Unusual Items -$1.4B $165M $323M $200M $160M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$342M $21M -$52M -$105M $482M
Net Income to Company -$632M $561M $854M $759M $150M
 
Minority Interest in Earnings $5M $65M $122M $110M $55M
Net Income to Common Excl Extra Items -$632M $561M $854M $759M $150M
 
Basic EPS (Cont. Ops) -$1.02 $0.77 $1.14 $1.01 $0.12
Diluted EPS (Cont. Ops) -$1.02 $0.77 $1.14 $1.00 $0.12
Weighted Average Basic Share $638.3M $629.4M $630M $633.8M $652.9M
Weighted Average Diluted Share $638.3M $632.2M $632.3M $638.1M $654M
 
EBITDA $1.1B $1.3B $1.3B $988M $1.3B
EBIT $640M $823M $692M $374M $627M
 
Revenue (Reported) $3.2B $3.8B $3.3B $2.7B $3.2B
Operating Income (Reported) $640M $823M $692M $374M $627M
Operating Income (Adjusted) $640M $823M $692M $374M $627M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $12.5B $15.1B $17.3B $12.6B $13.7B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $9B $11.1B $12.6B $9.5B $9.8B
Gross Profit $3.5B $4B $4.8B $3.1B $3.9B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $588M $628M $670M $683M $733M
Other Inc / (Exp) -$1.6B -$255M $32M $159M --
Operating Expenses $588M $628M $670M $683M $733M
Operating Income $2.9B $3.4B $4.1B $2.4B $3.2B
 
Net Interest Expenses $1B $1.2B $1.3B $1.2B $1.5B
EBT. Incl. Unusual Items $112M $1.7B $2.3B $1.7B $2B
Earnings of Discontinued Ops. $10M -- -- -- --
Income Tax Expense $144M $579M $620M -$72M $993M
Net Income to Company $3B $2.6B $3.2B $3.4B $2.6B
 
Minority Interest in Earnings $19M $284M $394M $433M $416M
Net Income to Common Excl Extra Items $1.2B $2.6B $3.2B $3.4B $2.6B
 
Basic EPS (Cont. Ops) $1.86 $3.57 $4.34 $4.57 $3.26
Diluted EPS (Cont. Ops) $1.84 $3.56 $4.32 $4.54 $3.25
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $4.7B $5.4B $6.3B $4.8B $5.8B
EBIT $2.9B $3.4B $4.1B $2.4B $3.2B
 
Revenue (Reported) $12.5B $15.1B $17.3B $12.6B $13.7B
Operating Income (Reported) $2.9B $3.4B $4.1B $2.4B $3.2B
Operating Income (Adjusted) $2.9B $3.4B $4.1B $2.4B $3.2B
Period Ending 2022-09-30 2023-09-30 2024-09-30 2025-09-30 2026-09-30
Revenue $11.4B $13.2B $9.2B $9.9B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $8.3B $9.5B $6.9B $7.2B --
Gross Profit $3.1B $3.7B $2.3B $2.7B --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $474M $509M $515M $555M --
Other Inc / (Exp) -$274M $19M $126M $109M --
Operating Expenses $474M $509M $515M $555M --
Operating Income $2.7B $3.2B $1.8B $2.2B --
 
Net Interest Expenses $808M $1B $934M $1.1B --
EBT. Incl. Unusual Items $1.2B $2.2B $1.2B $1.1B --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $435M $499M -$63M $711M --
Net Income to Company $1.9B $2.8B $2.5B $1.6B --
 
Minority Interest in Earnings $187M $435M $325M $103M --
Net Income to Common Excl Extra Items $1.9B $2.8B $2.5B $1.6B --
 
Basic EPS (Cont. Ops) $2.63 $3.64 $3.40 $2.21 --
Diluted EPS (Cont. Ops) $2.62 $3.63 $3.38 $2.21 --
Weighted Average Basic Share $1.9B $1.9B $1.9B $2B --
Weighted Average Diluted Share $1.9B $1.9B $1.9B $2B --
 
EBITDA $4.2B $4.9B $3.6B $4.1B --
EBIT $2.7B $3.2B $1.8B $2.2B --
 
Revenue (Reported) $11.4B $13.2B $9.2B $9.9B --
Operating Income (Reported) $2.7B $3.2B $1.8B $2.2B --
Operating Income (Adjusted) $2.7B $3.2B $1.8B $2.2B --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $982M $578M $410M $285M $1.6B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1.6B $2.1B $2.6B $2.2B $2B
Inventory $308M $389M $403M $482M $559M
Prepaid Expenses -- $260M $268M $273M $255M
Other Current Assets $892M $398M $541M $1.5B $311M
Total Current Assets $4.5B $4.4B $5.9B $5.5B $5.3B
 
Property Plant And Equipment $40.5B $44.5B $48.4B $55.7B $62.6B
Long-Term Investments $16.1B $16.5B $16.6B $17.9B $19.4B
Goodwill $1.6B $1.6B $1.6B $1.6B $1.6B
Other Intangibles $202M $370M $344M $318M $292M
Other Long-Term Assets $857M $1.7B $2.2B $2B $2.6B
Total Assets $66.6B $72B $78.6B $87.2B $96.2B
 
Accounts Payable $1.4B $1.7B $2B $2.2B $2.2B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $1.7B $1.6B $2B $3.1B $1.6B
Total Current Liabilities $6.8B $10B $9.9B $10.1B $9.7B
 
Long-Term Debt $21.8B $21.2B $25.1B $28.4B $31.8B
Capital Leases -- -- -- -- --
Total Liabilities $41.7B $44.6B $49.3B $53.5B $58.4B
 
Common Stock $7.1B $11.9B $12.2B $12.2B $13.5B
Other Common Equity Adj -$500M -$318M -$135M -$150M -$166M
Common Equity $20.2B $25.1B $26.2B $27.8B $30.3B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $1.5B $1.4B $2.1B $5B $6.5B
Total Equity $24.9B $27.4B $29.3B $33.7B $37.8B
 
Total Liabilities and Equity $66.6B $72B $78.6B $87.2B $96.2B
Cash and Short Terms $982M $578M $410M $285M $1.6B
Total Debt $23.3B $21.3B $26.1B $29.3B $34B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Cash and Equivalents $904M $734M $1.4B $582M $7M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $1.4B $1.8B $1.9B $1.7B $1.4B
Inventory $371M $506M $451M $519M $565M
Prepaid Expenses -- $333M $325M $314M $247M
Other Current Assets $1.3B $562M $395M $1.3B --
Total Current Assets $4.6B $4.5B $5.3B $5.1B $31.7B
 
Property Plant And Equipment $43.3B $47.1B $53.9B $60.2B $49.6B
Long-Term Investments $16.1B $16.3B $18B $19B $18.4B
Goodwill $1.6B $1.6B $1.6B $1.6B --
Other Intangibles $376M $350M $324M $299M --
Other Long-Term Assets $1.3B $2.2B $3.2B $2.8B --
Total Assets $70.5B $75.6B $85.7B $93.7B $106.9B
 
Accounts Payable $1.4B $1.9B $2.2B $2B $1.3B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $2.3B $1.7B $2B $2.9B --
Total Current Liabilities $12.9B $7.8B $8.8B $9.8B $20B
 
Long-Term Debt $20B $23.8B $27.7B $31B $29B
Capital Leases -- -- -- -- --
Total Liabilities $45.9B $46.3B $52.5B $57.9B $66.7B
 
Common Stock $10.8B $12.1B $12B $12.3B $14.2B
Other Common Equity Adj -$418M -$120M -$60M -$185M --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $30M $2.2B $5B $6.2B $9B
Total Equity $24.6B $29.3B $33.3B $35.9B $40.2B
 
Total Liabilities and Equity $70.5B $75.6B $85.7B $93.7B $106.9B
Cash and Short Terms $904M $734M $1.4B $582M $7M
Total Debt $23B $24.8B $28.7B $32.2B $30.9B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $4.1B $1.5B $2.3B $3.6B $3.5B
Depreciation & Amoritzation $1.7B $1.9B $2B $2.2B $2.4B
Stock-Based Compensation $71M $63M $71M $80M $86M
Change in Accounts Receivable -$421M -$514M -$616M $168M $118M
Change in Inventories -$35M -$87M -$17M -$80M -$74M
Cash From Operations $3.4B $4.2B $1.1B $6.2B $4.9B
 
Capital Expenditures $4.7B $5B $5.4B $8.4B $8.2B
Cash Acquisitions $652M $633M $376M $382M --
Cash From Investing -$182M -$2.7B -$3.3B -$5.9B -$7.9B
 
Dividends Paid (Ex Special Dividend) $1.3B $1.4B $1.5B $1.5B $1.5B
Special Dividend Paid
Long-Term Debt Issued $6.1B $3.8B $10B $7.7B $8.7B
Long-Term Debt Repaid -$5.9B -$5.5B -$4.5B -$6.3B -$3.3B
Repurchase of Common Stock $566M $339M $478M $32M $43M
Other Financing Activities -$207M $2.8B $1.5B $1.9B $1B
Cash From Financing -$2.4B -$1.9B $2B -$370M $4.2B
 
Beginning Cash (CF) $982M $578M $410M $285M $1.6B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $768M -$404M -$119M -$73M $1.2B
Ending Cash (CF) $1.7B $176M $290M $218M $2.8B
 
Levered Free Cash Flow -$1.3B -$807M -$4.2B -$2.2B -$3.3B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders -$632M $561M $854M $759M $150M
Depreciation & Amoritzation $471M $506M $563M $614M $662M
Stock-Based Compensation $14M $17M $22M $22M $14M
Change in Accounts Receivable -- $334M -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $1.1B -$909M $1.4B $1B $1.1B
 
Capital Expenditures $1.2B $1.2B $1.8B $1.9B $2.6B
Cash Acquisitions $51M $94M $97M -$387M --
Cash From Investing -$1.2B -$646M -$417M -$1.8B $224M
 
Dividends Paid (Ex Special Dividend) $356M $359M $375M $380M $408M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $1.7B $1.9B $1.3B $2.6B --
Long-Term Debt Repaid -$883M $189M -$2.2B -$1B --
Repurchase of Common Stock $1M $2M $1M $1M --
Other Financing Activities -$203M -$33M $1.4B $327M --
Cash From Financing $679M $249M -$725M $1.1B $1.5B
 
Beginning Cash (CF) $904M $734M $1.4B $582M $7M
Foreign Exchange Rate Adjustment -$1M -$1M -$1M -$3M $4M
Additions / Reductions $536M -$1.3B $249M $339M $2.8B
Ending Cash (CF) $1.4B -$574M $1.6B $918M $2.9B
 
Levered Free Cash Flow -$91M -$2.1B -$400M -$913M -$1.5B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $3B $2.6B $3.2B $3.4B $2.6B
Depreciation & Amoritzation $1.8B $2B $2.2B $2.4B $2.6B
Stock-Based Compensation $62M $64M $75M $90M $48M
Change in Accounts Receivable -$225M -$195M -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $4.3B $2.3B $4.8B $4.6B $4.7B
 
Capital Expenditures $5B $4.9B $7.9B $8.1B $9.7B
Cash Acquisitions $639M $692M $382M $101M --
Cash From Investing -$5.7B -$290M -$5.9B -$7.1B -$8B
 
Dividends Paid (Ex Special Dividend) $1.4B $1.5B $1.5B $1.5B $1.6B
Special Dividend Paid
Long-Term Debt Issued $2.1B $8.5B $10.2B $7.2B --
Long-Term Debt Repaid -$1.9B -$6.5B -$7.2B -$2.5B --
Repurchase of Common Stock $40M $778M $32M $41M $60M
Other Financing Activities -$251M $4.6B $1.8B $999M --
Cash From Financing -$1.3B -$2.1B $1.8B $1.7B $5.6B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$2.6B -$121M $705M -$801M $2.3B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$661M -$2.6B -$3.1B -$3.5B -$4.9B
Period Ending 2022-09-30 2023-09-30 2024-09-30 2025-09-30 2026-09-30
Net Income to Stockholders $1.9B $2.8B $2.5B $1.6B --
Depreciation & Amoritzation $1.5B $1.7B $1.8B $2B --
Stock-Based Compensation $49M $53M $63M $25M --
Change in Accounts Receivable $350M -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $1.5B $5.1B $3.5B $3.4B --
 
Capital Expenditures $3.5B $6.1B $5.8B $7.2B --
Cash Acquisitions $275M $281M -- -- --
Cash From Investing -$1.4B -$4B -$5.2B -$5.3B --
 
Dividends Paid (Ex Special Dividend) $1.1B $1.1B $1.1B $1.2B --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $6.7B $6.9B $6.4B $5.5B --
Long-Term Debt Repaid -$3.4B -$6B -$2.2B -$3.4B --
Repurchase of Common Stock $478M $32M $41M $58M --
Other Financing Activities $1.6B $1.8B $932M $10M --
Cash From Financing $189M -$76M $1.9B $3.3B --
 
Beginning Cash (CF) $5.3B $3.2B $1.6B $1.9B --
Foreign Exchange Rate Adjustment -$3M $6M -$11M $4M --
Additions / Reductions $205M $1B $301M $1.4B --
Ending Cash (CF) $5.5B $4.2B $1.8B $3.4B --
 
Levered Free Cash Flow -$2.1B -$945M -$2.2B -$3.8B --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Sell
50
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
40
Is GOOGL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 29x

Alerts

Buy
77
RNG alert for Feb 23

RingCentral, Inc. [RNG] is down 8.48% over the past day.

Sell
9
FROG alert for Feb 23

JFrog Ltd. [FROG] is down 4.21% over the past day.

Buy
72
SNSE alert for Feb 23

Sensei Biotherapeutics, Inc. [SNSE] is down 6.51% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock